How access to mRNA Covid vaccines is dividing the world between haves and have-nots
Only a handful of facilities in the US and Western Europe account for almost all of the world’s mRNA vaccine supply leaving many countries in a desperate race to catch up.
Bruce Einhorn 16 July, 2021 10:26 am IST Text Size:
A+
Hong Kong: The latest surge in Covid-19 cases is widening one of the biggest inequities of the pandemic era: The gap between nations that have messenger RNA vaccines and those that don’t.
The cutting-edge technology, which made its debut during the pandemic, has proven more effective than any other in staving off infections and serious illness from the coronavirus. Yet just a handful of facilities in the U.S. and Western Europe account for almost all of the world’s mRNA vaccine supply leaving many countries in a desperate race to catch up.
World carved up into haves and have-nots by mRNA vaccine access
japantimes.co.jp - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japantimes.co.jp Daily Mail and Mail on Sunday newspapers.
Seúl cede un 0,28 % tras la caída de Wall Street y ante subida de contagios - Mundo
abc.com.py - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abc.com.py Daily Mail and Mail on Sunday newspapers.
Advertisement
Australia is likely to take until 2023 to produce its own messenger RNA vaccines like those from Pfizer and Moderna, as scientists call for a huge federal investment to match countries that already have manufacturing deals.
The federal government is expecting several commercial bids this Friday to build local facilities to produce the mRNA vaccines, but its plans rely heavily on talks with Moderna to lure the US company.
The federal government’s plan to produce mRNA vaccines relies heavily on talks with Moderna to lure the US company.
Credit:Getty
Australia is already two months behind other countries in the region in signing a major global partner for local mRNA facilities after Singapore, South Korea and China struck agreements in May for domestic production.
07 15 21 -- Implementing DSCSA With New FDA Guidances
pharmaceuticalonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceuticalonline.com Daily Mail and Mail on Sunday newspapers.